Name: AURINIA PHARMACEUTICALS INC (AUPH) Stock
Brand: AURINIA PHARMACEUTICALS INC
Rating: 8 (3 reviews)

AUPH Latest News, Press Relases and Analysis

All

Press Releases

15 days ago - By: Chartmill

AURINIA PHARMACEUTICALS INC (NASDAQ:AUPH) Passes Louis Navellier's Strict Growth Stock Screen

15 days ago - By: Zacks Investment Research

Can Aurinia (AUPH) Run Higher on Rising Earnings Estimates?

18 days ago - By: Benzinga - Mentions: KURA SEE HRMY FOLD ...

Earnings Scheduled For November 4, 2025

18 days ago - By: Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2025 and Provides Update on Recent Business Progress

19 days ago - By: Benzinga

A Peek at Aurinia Pharmaceuticals's Future Earnings

19 days ago - By: Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals to Report Financial Results for the Three and Nine Months Ended September 30, 2025 and Provide Update on Recent Business Progress on November 4, 2025

20 days ago - By: Stocktwits - Mentions: XBI VTI NYT

FDA Turmoil Spills Over To Aurinia Pharma As Lawsuit Targets Ex-Drug Review Chief — Retail Traders Cry ‘Stock Manipulation’

a month ago - By: Aurinia Pharmaceuticals Inc.

Aurinia Announces Upcoming Presentations of New Data on LUPKYNIS® at American College of Rheumatology Convergence and American Society of Nephrology Kidney Week 2025

2 months ago - By: Stocktwits

Aurinia Pharma Stands By Lupus Drug After FDA Official’s Retracted Post Sparks 16% Selloff — Retail Stays Bullish On Recovery

2 months ago - By: Aurinia Pharmaceuticals Inc.

Aurinia Responds to Now Retracted LinkedIn Post

2 months ago - By: Bloomberg

Aurinia Sinks After FDA Official Questions Its Drug on LinkedIn

2 months ago - By: Investor's Business Daily - Mentions: UTHR HALO ARGX

United Therapeutics Price Strength Rating Jumps After Its Stock Soared 33% Last Week On Positive Drug Test Results

3 months ago - By: Investor's Business Daily - Mentions: ARGX HALO RIGL

Argenx Stock Hits Record High After Reporting 664% Earnings Surge; This Rating Upgraded

4 months ago - By: Zacks Investment Research

Aurinia (AUPH) Upgraded to Buy: Here's What You Should Know

4 months ago - By: Investor's Business Daily - Mentions: GILD INCY KNSA

Gilead Sciences Reports Earnings Thursday. Can The Highly Ranked Drugmaker Beat Its 237% Profit Surge Last Quarter?

4 months ago - By: The Motley Fool

Aurinia (AUPH) Q2 Revenue Jumps 22%

4 months ago - By: Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2025

4 months ago - By: Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals to Release Second Quarter 2025 Financial and Operational Results on July 31, 2025

5 months ago - By: Aurinia Pharmaceuticals Inc.

Aurinia Announces Positive Results from Phase 1 Study of Aritinercept (AUR200)

5 months ago - By: Stocktwits

Retail Bulls Charge Into Aurinia Pharmaceuticals Ahead Of Autoimmune Trial Results